Diffusion and Perfusion: The Keys to Fat Grafting by Khouri, Roger K. et al.
 
Diffusion and Perfusion: The Keys to Fat Grafting
 
 
(Article begins on next page)
The Harvard community has made this article openly
available.
Please share how this access benefits you. Your story
matters.
Citation Khouri, Roger K., Raoul-Emil R. Khouri, Jorge R. Lujan-
Hernandez, Khalil R. Khouri, Luca Lancerotto, and Dennis P.
Orgill. 2014. “Diffusion and Perfusion: The Keys to Fat




Accessed February 17, 2015 6:17:00 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:13454752
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and
conditions applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAA www.PRSGlobalOpen.com  1
A
utologous fat grafting is increasingly used for 
breast augmentation and reconstruction.1–5 
Fat grafts are easily available, biocompatible, 
cause low donor-site morbidity, and give grafted 
sites a natural appearance. However, fat grafting is 
generally considered an unpredictable procedure,6 
with long-term retention commonly varying between 
10% and 80%.7–14 Much work has been done to op-
timize this procedure; however, the clinical practice 
has advanced faster than the supporting science. Fat 
grafting can be considered in 4 phases: harvesting, 
processing, reinjecting, and managing the recipi-
ent site.15 To determine the optimal surgical meth-
ods for harvesting, processing, and reinjecting, 
Gir et al6 completed an extensive literature review. 
Their results show the variability of current surgical 
techniques with current literature only supporting 
general principles and not any specific technique. 
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Background: Fat grafting is now widely used in plastic surgery. Long-term 
graft retention can be unpredictable. Fat grafts must obtain oxygen via 
diffusion until neovascularization occurs, so oxygen delivery may be the 
overarching variable in graft retention.
Methods: We studied the peer-reviewed literature to determine which as-
pects of a fat graft and the microenvironment surrounding a fat graft affect 
oxygen delivery and created 3 models relating distinct variables to oxygen 
delivery and graft retention.
Results: Our models confirm that thin microribbons of fat maximize oxygen 
transport when injected into a large, compliant, well-vascularized recipient 
site. The “Microribbon Model” predicts that, in a typical human, fat injec-
tions larger than 0.16 cm in radius will have a region of central necrosis. Our 
“Fluid Accommodation Model” predicts that once grafted tissues approach a 
critical interstitial fluid pressure of 9 mm Hg, any additional fluid will drasti-
cally increase interstitial fluid pressure and reduce capillary perfusion and 
oxygen delivery. Our “External Volume Expansion Effect Model” predicts 
the effect of vascular changes induced by preoperative external volume ex-
pansion that allow for greater volumes of fat to be successfully grafted.
Conclusions: These models confirm that initial fat grafting survival is lim-
ited by oxygen diffusion. Preoperative expansion increases oxygen diffu-
sion capacity allowing for additional graft retention. These models provide 
a   scientific framework for testing the current fat grafting theories. (Plast 
Reconstr Surg Glob Open 2014;2:e220; doi: 10.1097/GOX.0000000000000183; 
Published online 26 September 2014.)
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Furthermore, no experimental or theoretical studies 
have analyzed how the different surgical methods al-
ter the microenvironment surrounding the graft or 
how the microenvironment affects graft retention.
In this context, we define a model as a conceptual 
and mathematical representation of a phenomenon 
that has occurred in the past in an attempt to predict 
how it will occur in the future as specific variables 
change. Modeling has been critical for many advanc-
es in plastic surgery. Our group has modeled both 
skin expansion and the mechanical forces involved 
in vacuum-assisted closure devices.16,17 These mod-
els have helped enhance our understanding of the 
biological effects and medical uses of mechanical 
forces. Modeling provides the theoretical framework 
for testing theories. This study aims to identify the 
role of the recipient site in fat grafting and create a 
model to serve as a scientific basis to analyze the vari-
ables related to the recipient site and graft retention.
Grafted fat initially lacks vascular support and 
must receive oxygen and nutrients by diffusion from 
nearby capillaries until neovascularization occurs.18 
Oxygen seems to be the critical molecule required 
for cell survival. Low oxygen partial pressures in the 
center of the graft can lead to cell necrosis. Attempts 
to improve graft retention have largely been based on 
the “cell survival theory,” which states that long-term 
graft volume consists primarily of grafted adipocytes 
that have survived the entire procedure.15 This theory 
has generally been accepted18,19 and has directed most 
efforts to maintaining adipocytes viability through 
improved harvesting, processing, and reinjecting 
techniques.19–21 Studies supporting the cell survival 
theory claim that the “viable zone” (40% adipocyte 
survival) reaches as far down as 0.2  cm from the pe-
riphery of the grafted tissue.22 These conclusions are 
based mostly on morphological observations with 
H&E staining. However, judging adipocyte health by 
shape or nuclear appearance can be misleading, and 
histologic sections are too thin to show most nuclei 
of healthy adipocytes.23 Moreover, the “cell survival 
theory” may fail to get to the complex phenomena 
occurring in fat grafting. Fat grafts are not pure ag-
gregates of adipocytes, but a mixture of adipocytes, 
preadipocytes, endothelial cells, pericytes, stem cells, 
fibroblasts, inflammatory cells, and matrix.
Using immunostain for perilipin, a method for 
determining adipocyte viability,24 Eto et al23 in the Yo-
shimura Lab tested the cell survival theory and con-
cluded that a dynamic remodeling of grafted adipose 
tissue (AT) occurs. In hypoxic cell cultures, they dem-
onstrated that adipocytes cannot survive more than 1 
day of severe ischemia-mimicking conditions (1% O2 
with no serum), whereas adipose-derived stromal cells 
(ASCs) remained viable for up to 72 hours. In a sec-
ond experiment, the inguinal fat pad of a mouse was 
grafted to the scalp. Only the peripheral area (surviv-
ing zone; <0.03 cm from the edge) of the graft had a 
high survival rate of both adipocytes and ASCs. In a 
deeper (regenerating) zone, most adipocytes did not 
survive more than 1 day, but ASCs survived and even-
tually provided new adipocytes. By day 3, the number 
of proliferating cells increased, and by day 7, they 
found an increased thickness of the zone with viable 
adipocytes. At the center of the graft, no AT survived, 
and macrophages removed the dead cells25; this was 
named the “necrotic zone.”
Recent studies support this “host replacement 
theory.” Rigamonti et al26 suggest that 4.8% of pre-
adipocytes are replicating at any time, and 1–5% of 
adipocytes are replaced each day. When mouse AT 
oxygenation reaches less than 65% of baseline, adipo-
cytes undergo apoptosis in 24 hours; however, ASCs 
can survive for multiple days in severe hypoxia.27 
Hypoxia is known to enhance ASC proliferation.28,29 
Injured adipocytes release fibroblast growth factor-2, 
which stimulates ASC proliferation and hepatocyte 
growth factor, contributing to the regeneration of 
AT.30 The retention of grafted fat largely depends on 
the distance metabolites must travel to reach the cen-
ter of the graft and on the depths of the surviving and 
regenerating zones.
MATERIALS AND METHODS
We searched Pubmed for original articles with 
the term “fat grafting” in the title or abstract to de-
termine which aspects of the microenvironment sur-
rounding fat grafts affect retention. We modeled the 
relationship between oxygen consumption by me-
tabolizing fat tissue and oxygen delivery via diffusion 
for grafted fat cylinders of varying radii. We called 
this the “Microribbon Model.”
In a steady state, oxygen delivery matches oxygen 
consumption, and oxygen must diffuse off erythro-
cytes, through the capillary walls, through the extra-
cellular space, and into the grafted cells. To optimize 
the potential for oxygen delivery, the vascular per-
fusion must be functioning properly, and several 
articles propose that an increased interstitial fluid 
pressure (IFP) during fat grafting might restrict 
perfusion. To determine the physiological plausibil-
ity of this hypothesis, we modeled the relationship 
between fluid accumulation, IFP, and perfusion. We 
called this the “Fluid Accommodation Model.”
To study how the information from the first 2 
models can be used to optimize the fat grafting pro-
cedure, we explored which existing fat grafting pro-
cedures were attempting to optimize the variables in   Khouri et al. • Diffusion and Perfusion
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our models. Although several articles emphasized a 
biological approach with cytokines and stem cells, 
only external volume expansion (EVE) emphasized 
enhancing oxygen delivery. Therefore, we modeled 
how EVE could prepare the recipient site to allow the 
critical variables in the first 2 models to be optimized 
during fat grafting. We called this the “EVE Effect 
Model.” The information from these models comes 
from our calculations derived from established equa-
tions, relationships, and constants.
RESULTS
The literature to date concludes that oxygen de-
livery seems to be the most crucial molecule for fat 
graft survival. The thickness of the exterior rim of 
viable cells in multicell spheroids increases linearly 
with the theoretical oxygen diffusion distance.31 Oxy-
gen diffusion is the limiting variable in determining 
cell survival in spheroids.32 Therefore, it seems that 
the core principle of fat graft survival is that oxygen 
concentration at any point in a graft is a function of 
the oxygen concentration of the surrounding cap-
illaries, the diffusion rate of oxygen to reach that 
point in the tissue, the distance from the oxygen 
source, and the metabolic rate. In other words, at 
every point within a fat graft, there is a race between 
the rate at which oxygen is needed by the cells and 
the rate at which oxygen can be delivered by the cap-
illaries and diffused through the AT.
According to standard principles in physiology, 
the metabolic rate of a given section of AT is directly 
proportional to its volume (V). However, the diffu-
sion rate of any substance is directly proportional 
to the surface area (SA) over which diffusion takes 
place, and the SA:V ratio of any interior section of a 
cylinder is (2/radius). Therefore, as the radius of a 
cylindrical injection of AT increases, the SA:V ratio 
decreases, and oxygen’s diffusion rate cannot meet 
the tissue’s metabolic needs. In addition, diffusion 
is related to the square of the distance between the 
oxygen source and where it is consumed. When the 
distance is increased by a factor of 2, the delivery of 
oxygen is decreased by a factor of 4.
Using diffusion and metabolism equations and 
biological and physical constants,31–37 we modeled 
the theoretical borders between the surviving, re-
generating, and necrotic zones for fat grafts of dif-
ferent radii (Appendix 1) (Fig. 1). According to the 
Microribbon Model in standard human conditions, 
the largest fat microribbon with no necrotic zone 
would have a radius of 0.16  cm. Such a graft would 
have a surviving zone of 0.03 cm and a regenerating 
zone of 0.13 cm. As graft radius increases beyond this 
point, the necrotic zone grows rapidly.
This Microribbon Model correlates well with exper-
imental data. When multicell spheroids were cultured 
in excess medium, the spheroids ceased to expand at 
a radius of 0.15  cm.38 Carpaneda and Ribeiro22 sug-
gest that, in humans, only the region 0.15  cm from 
the edge of a fat graft retains a significant percent of 
its volume. Current successful method descriptions 
suggest a 0.13-cm limit for the radius of reinjected 
fat.39,40 Multiple studies report negative correlation 
between fat graft particle width and retention per-
centage.8,15,25,41 Long-term fat graft retention requires 
small volumes of fat to be diffusely distributed into a 
well-vascularized recipient site through well-separated 
tunnels.1,4,8,41–43 If the microinjections are not diffusely 
distributed in the recipient site, they will coalesce, 
forming particles too wide to survive.25,39,40
Fat graft survival is also largely dependent on the 
vasculature’s ability to delivery oxygen blood through 
Fig. 1. a, theoretical representation of oxygen concentration at the center of a fat graft as a function of its radius. there are 3 
zones of oxygen concentration. the surviving zone has C > Ca. the regenerating zone has Ca > C > CS. the necrotic zone has 
C < CS.20 B, Cross-sectional views of cylindrical fat injections, showing [O2] as a function of radial distance. a, Cylindrical injec-
tion with R = Rcrit. adipocytes only survive in the outer 0.03 cm. aSCs survive throughout. b, Cylindrical injection with R > Rcrit. 
adipocytes only survive in the outer 0.02 cm. aSCs only survive in the outer 0.08 cm. no cells survive in the inner 0.12 cm.PRS Global Open • 2014
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the capillaries surrounding the graft.39,40,44,45 Several 
surgeons have suggested that injecting too much fat 
into a small recipient site can increase IFP enough to 
constrict capillaries, inducing ischemia in the grafted 
tissues.5,15,39,40,45 Guyton46 demonstrated that, for up 
to a certain volume, interstitial fluid can accumu-
late in a tissue without significant IFP increase, but 
beyond that range, any additional fluid causes dras-
tic IFP increases, quickly reaching levels associated 
with compartment syndrome.47 Milosevic et al48 also 
demonstrated that capillary perfusion decreases with 
increasing IFP. Therefore, it is recognized that fluid 
accumulation can lead to increased IFP and that in-
creased IFP can lead to decreased capillary perfusion.
Using these relationships, we modeled the change 
in relative capillary perfusion as a function of IFP 
and interstitial fluid accumulation to determine 
if increased IFP during fat graft is enough to limit 
capillary perfusion and oxygen delivery (Fig. 2). Ac-
cording to this Fluid Accommodation Model, a given 
tissue compartment can accommodate about 60% of 
its weight in interstitial fluid before reaching a criti-
cal IFP (IFPC) of 9 mm Hg, beyond which, any addi-
tional fluid causes a drastic IFP increase and capillary 
perfusion decrease. It is important to recognize that 
this 60% accommodation is a generalized estimation, 
which will change with differences in the compliance 
of tissues; therefore, the IFP could be monitored in-
traoperatively if excess fat injections could be a pos-
sibility.39,40 This IFPC closely correlates with recent 
suggestions of IFP-based fat grafting stop points of 
9–10 mm  Hg.39,40,49,50 Increased IFP may also inhibit 
retention of grafted cells by mechanical compres-
sion, which induces apoptosis and regulates cytokine 
release.51 Therefore, interstitial volume, compliance, 
and vascularity determine how many microribbons of 
fat can be dispersed before increasing IFP enough to 
significantly reduce perfusion and cell survival.
Mechanical forces can induce angiogenesis, 
adipogenesis, and increased subcutaneous tissue 
thickness and compliance.16,39,40,45,52–58 Our group 
previously studied the mechanism behind EVE’s ef-
fects54 and found that the macroscopic swelling is 
likely due to deformation of the extracellular matrix, 
which induces tension on the cells anchored to extra-
cellular matrix fibers. This micromechanical strain is 
transferred to the cytoskeleton,59 where it acts as a 
gate-control signal to induce proliferation.60 EVE-in-
duced ischemia activates the hypoxia inducible fac-
tor -1α/vascular endothelial growth factor pathway 
to induce vascular remodeling, angiogenesis, and 
cell proliferation.55 Adipogenesis can be induced by 
Fig. 2. iFP as a function of percent change in leg weight by saline injection in isolated dog 
hindleg (black).46 Mathematical model of relative capillary blood flow as a function of iFP 
(blue).48 iFPC = iFP at which perfusion becomes compromised quickly; fat grafting should be 
stopped at this point.  Khouri et al. • Diffusion and Perfusion
5
lymphedema or water-rich empty proteinaceous ma-
trices.61–69 Inflammation promotes these processes.70
Khouri et al56 developed a suction-based EVE 
bra (BRAVA) that noninvasively induces long-term 
breast growth in humans.71 It uses cyclical forces, 
which have a greater effect than continuous forces.16 
Daily BRAVA-use induces temporary edema and 
angiogenesis and sustained increases in subcutane-
ous tissue thickness and compliance.39,45,56 Once fat 
grafting to the breast was more accepted and un-
derstood, BRAVA was proposed for application in 
preparation for fat grafting. Pre-expansion and re-
sultant augmentation had a strong linear correlation 
(R2 = 0.87), and pre-expansion allowed significantly 
more AT to be grafted and retained than what was 
reported in a meta-analysis of 6 other published re-
ports on fat graft breast augmentation without pre-
expansion (P < 0.00001).45 Preoperative expansion 
also has several clinical applications in breast aug-
mentation and reconstruction (Khouri et al, unpub-
lished data, 2014).5,39,40,45,49,72,73
To understand the effectiveness of EVE devices 
for fat grafting, we must consider the ratio of grafted 
fat to recipient site volume. If the original recipient 
site is 100  mL and noncompliant, and 30  mL of AT 
are to be grafted, there is no need for pre-expansion 
because, with a 30% increase, the AT can be diffusely 
microinjected. If the original recipient site is 100 mL, 
and the volume of AT to be grafted is 90  mL, this 
90% increase cannot be done without overcrowd-
ing, which would cause coalescence, increased IFP, 
reduced perfusion and oxygen delivery, thinner sur-
Fig. 3. a, Fat-grafting process without BraVa. Overcrowding causes coalescence and high 
iFP, which cause insufficient oxygen delivery, leading to central necrosis, volume loss, and 
microcalcification. B, relative iFP throughout fat-grafting process with eVe. long-term eVe 
expands tissues and causes an influx of edema, according to the Starling equation. Because 
the tissue is pre-expanded, as fat is injected, less coalescence occurs and more fat can be 
grafted before iFP reaches iFPC. as pressure increases, edema quickly leaves the tissues, al-
lowing pressure to return to baseline levels.PRS Global Open • 2014
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viving and regenerating zones, and significant vol-
ume loss (Fig. 3A). However, our EVE Effect Model 
  predicts that a tight 100-mL recipient site can be 
transformed into a compliant 300-mL site and, ac-
cording to the Starling equation, cause edema influx. 
Because the fat microribbons can be diffusely dis-
persed into the pre-expanded tissue, less coalescence 
occurs and more AT can be grafted before reaching 
IFPC. As IFP increases, the Starling equation dictates 
that interstitial fluid is reabsorbed, allowing IFP to 
quickly return to baseline levels (Fig. 3B).
Our EVE Effect Model also predicts that the 
preoperative cyclical negative pressure treatment 
increases the host vascular density and diameter, in-
creasing total oxygenated blood delivery, decreasing 
the mean distance each oxygen molecule must dif-
fuse to reach the center of a grafted microribbon, 
and accelerating graft revascularization: a major de-
terminant of volume retention (Fig. 4).25,42,73–76
DISCUSSION
We have presented 3 models to predict how recip-
ient site vascularity, volume, and compliance deter-
mine fat graft retention by regulating oxygen delivery 
via perfusion and diffusion. To the best of our knowl-
edge, this is the first study to mathematically model 
the essential variables relating to oxygen delivery and 
graft retention. The information from these models 
comes from our calculations derived from established 
equations, relationships, and constants. Our Micror-
ibbon Model suggests that any fat injection with a 
radius greater than 0.16 cm in standard human con-
ditions will have a zone of central necrosis. Our Fluid 
Accommodation Model suggests that interstitial fluid 
injections that cause IFP to increase past IFPC will re-
strict perfusion. Our EVE Effect Model explains how 
the information from the first 2 models can be used 
to optimize the fat grafting procedure. It predicts that 
preoperative EVE increases recipient site vascularity, 
volume, and compliance, allowing more AT to be 
successfully grafted. For grafting small volumes of fat 
into large, compliant, highly vascularized recipient 
sites, the recipient bed will likely accept the graft even 
if the surgeon does not specifically consider each of 
the variables in these models. However, for grafting 
large volumes of fat into small, restricted, poorly vas-
cularized recipient sites for procedures such as total 
breast reconstruction, or irradiated tissues, surgeons 
must optimize each of the variables related to graft 
retention. None of these models can predict fat graft 
retention on their own, but taken together, they en-
hance our understanding of the biological events oc-
Fig. 4. a, at baseline, iFP is at basal state, so capillary radius is at basal state, and native fat 
receives sufficient oxygen delivery. B, When large volumes of fat are grafted without pre-ex-
pansion, fat particles coalesce and iFP increases, causing decreased capillary radius and oxy-
gen delivery to grafted fat. C, When the same volume of fat is grafted with pre-expansion, fat 
particles remain diffusely distributed and iFP remains below iFPC, so capillary radius remains 
uncompromised, and the grafted fat receives sufficient oxygen delivery.  Khouri et al. • Diffusion and Perfusion
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curring during fat grafting and allow us harness this 
knowledge to enhance surgical outcomes.
Modeling provides the theoretical framework 
for testing theories, so these models require experi-
mental data to be further accepted. To test the Mi-
croribbon Model, experiments similar to the ones 
performed by Eto et al23 would have to be repro-
duced, but pO2 would have to be measured at vari-
ous depths within grafts or cylindrical cell cultures 
of various radii. To test the Fluid Accommodation 
Model, studies would have to measure IFP, perfu-
sion, and pO2 as fluid is injected into living tissue. 
To test the EVE Effect Model, a complex set of ex-
periments would be required. More importantly, to 
truly test the effects of EVE in fat grafting, a large 
prospective randomized controlled trial should be 
performed. It is hoped that these studies will lead to 
long-term prospective studies in humans.
CONCLUSION
Our models predict the following: that  fat injections 
larger than 0.16 cm in radius will have an area of central 
necrosis; that, in fat grafting, IFPs greater than 9 mmHg 
will cause decreased capillary perfusion; and that EVE 
can enhance tissue volume, vascularity, and compli-
ance, allowing more AT to be successfully grafted.
Dennis P. Orgill, MD, PhD
Division of Plastic Surgery
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APPENDIx 1
The following formulas model O2 diffusion into a metabolizing cylinder of tissue33:
1. C = C0 − (M/4D)[(R2 − r2) − a2 ln(R2/r2)]
2. a2 = [1 + ln(R2/a2)] = R2 − (Rcrit)2
3.   Rcrit = sqrt(4DC0/M)
C = [O2] at a radial distance (r) cm from the center of a cylinder (μmol/mL)
C0 = [O2] at the surface of a cylinder of radius R cm (μmol/mL)
CS = min [O2] at which ASCs can survive (μmol/mL)
CA = min [O2] at which adipocytes can survive (μmol/mL)
M = metabolic rate [μmol/(mL × min)]
D = O2 diffusion coefficient (cm2/min)
Rcrit = largest radius (R) such that ASCs survive throughout the graft (cm)
a = max radial distance (r) at which [O2] = 0 when R > Rcrit (cm)
rma = min distance from center (r) at which adipocytes can survive (cm)
Using these equations and established constants,23,31–34 we calculated that Rcrit = 0.16 cm.
When R = Rcrit, rma = 0.13 cm.